09.15.25 -- Helping Quiet Life Science Leaders Be Seen, Heard, And Valued

There were three new approvals across the therapeutic landscape in the second quarter of 2025, but despite those positive signs, overall dealmaking was flat for the quarter.

Examine the transformative landscape of medical monitoring in clinical trials with an emphasis on the shift from conventional retrospective reviews to a proactive, risk-based methodology.

Analytical technologies like Droplet Digital PCR (ddPCR) provide a more rapid and robust approach to nucleic acid quantification for better sensitivity, accuracy, and precision in therapeutic development.

Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.

This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and presents case studies on how composition changes during the concentration process can be effectively characterized.

Explore project continuity for a pharmaceutical client during restructuring by providing trained on-site experts, implementing operational excellence, and meeting milestones despite senior staff turnover.